BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1722380)

  • 1. Effect of lorglumide (CR-1409) on pancreatic secretory and trophic response to caerulein in newborn rats.
    Papp M; Varga G; Folly G
    Acta Physiol Hung; 1991; 78(1):61-7. PubMed ID: 1722380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
    Varga G; Papp M; Scarpignato C
    Fundam Clin Pharmacol; 1989; 3(3):295-306. PubMed ID: 2475419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
    Scarpignato C; Varga G; Dobronyi I; Papp M
    Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretin potentiates, caffeine does not affect caerulein--stimulated pancreatic enzyme depletion and growth in newborn rats.
    Papp M; Ammann RW; Dobronyl I; Varga G
    Z Gastroenterol; 1990 Apr; 28(4):188-91. PubMed ID: 1698000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
    Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
    Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caerulein in supramaximal doses fails to stimulate pancreatic growth, but it forces secretory granulopoiesis.
    Varga G; Papp M; Solomon TE; Scarpignato C; Tóth IE; Szabó D
    Acta Physiol Hung; 1988; 71(1):99-106. PubMed ID: 2455434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bombesin-induced pancreatic secretion and growth in rats: effect of proglumide, spantide and ranitidine.
    Scarpignato C; Varga G; Dobronyi I; Papp M
    Int J Tissue React; 1990; 12(5):299-307. PubMed ID: 1711515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine inhibits the trophic effect of caerulein on the pancreas in rats (preliminary data).
    Hidvégi E; Varga G; Papp M; Folly G; Scarpignato C
    Acta Physiol Hung; 1984; 64(3-4):475-8. PubMed ID: 6085212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
    Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C
    Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat.
    Sperti C; Militello C; Rovati L; Behboo R; Khajeturian E; Perasole A; Alaggio R; Pedrazzoli S
    J Surg Oncol; 1994 Sep; 57(1):11-6. PubMed ID: 8065144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of treatment with submaximal and excessive doses of caerulein on pancreatic growth in newborn rats.
    Papp M; Dobronyi I; Varga G
    Acta Physiol Hung; 1989; 73(2-3):311-3. PubMed ID: 2596320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
    Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
    Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of some gastrointestinal peptides on pancreatic growth in rats (preliminary results).
    Varga G; Solomon TE; Papp M
    Acta Physiol Hung; 1989; 73(2-3):319-21. PubMed ID: 2480697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
    Rodriguez AI; Manso MA; Garcia-Montero AC; Orfao A; de Dios I
    Pancreas; 1997 Oct; 15(3):314-22. PubMed ID: 9336798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trophic response and morphological changes in pancreas of caerulein treated rats: dose and time dependent effects.
    Mansi C; Mela GS; Ceppa P; Sciaba L; Barreca A; Pasini D; Grosso M; Corti L; Celle G
    Ital J Gastroenterol; 1990 Apr; 22(2):59-63. PubMed ID: 1720057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of long-term administration of lorglumide (CR 1409) on rat pancreatic growth and enzyme composition.
    Takács T; Nagy I; Pap A; Varró V
    Pancreas; 1990 Sep; 5(5):606-10. PubMed ID: 1700417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats.
    Yamamoto M; Otani M; Jia DM; Fukumitsu K; Yoshikawa H; Akiyama T; Otsuki M
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G681-7. PubMed ID: 12801885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caerulein stimulates pancreatic growth and somatic growth in suckling rats.
    Papp M; Varga G; Dobronyi I
    Int J Pancreatol; 1987 Jun; 2(3):171-81. PubMed ID: 2445876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
    Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
    Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.